Bioinformatic Analysis of the Urine Proteome of Acute Allograft Rejection
Authors:
- Edmond O’rIordanEOEdmond O’rIordan
- Tatyana N. OrlovaTOTatyana N. Orlova
- Jianfeng Mei JJJJianfeng Mei J
- Khalid ButtKBKhalid Butt
- Praveen M. ChanderPCPraveen M. Chander
- Shafiq RahmanSRShafiq Rahman
- Muong MyaMMMuong Mya
- Rena HuRHRena Hu
- Jahangir MominJMJahangir Momin
- Elizabeth W. EngEEElizabeth W. Eng
- Dierk J. HampelDHDierk J. Hampel
- Bertram HartmanBHBertram Hartman
Open Access
- 1 December 2004
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 15 (12) , 3240-3248
Abstract
The urinary proteome in health and disease attracts increasing attention because of the potential diagnostic and pathophysiologic biomarker information carried by specific excreted proteins or their constellations. This cross-sectional study aimed to analyze the urinary proteome in patients with biopsy-proven acute rejection (n = 23) compared with transplant recipients with stable graft function (n = 22) and healthy volunteers (n = 20) and to correlate this with clinical, morphologic, and laboratory data. Urine samples were preadsorbed on four different protein chip surfaces, and the protein composition was analyzed using a surface-enhanced laser desorption/ionization time-of-flight mass spectrometer platform. The data were analyzed using two independent approaches to sample classification. Patients who experienced acute rejection could be distinguished from stable patients with a sensitivity of 90.5 to 91.3% and a specificity of 77.2 to 83.3%, depending on the classifier used. Protein masses that were important in constructing the classification algorithms included those of mass 2003.0, 2802.6, 4756.3, 5872.4, 6990.6, 19,018.8, and 25,665.7 Da. Normal urine was distinguished from transplant urine using a protein marker of mass 78,531.2 Da with both a sensitivity and a specificity of 100%. In conclusion, (1) urine proteome in transplant recipients with stable graft function was significantly different from healthy control subjects, and (2) acute rejections were characterized by a constellation of excreted proteins. Analysis of the urinary proteome may expedite the noninvasive prediction of acute graft rejection, thus importantly assisting in establishing the diagnosis.Keywords
This publication has 15 references indexed in Scilit:
- Urine protein profiling with surface-enhanced laser-desorption/ionization time-of-flight mass spectrometryKidney International, 2004
- Molecular Heterogeneity in Acute Renal Allograft Rejection Identified by DNA Microarray ProfilingNew England Journal of Medicine, 2003
- Comparison of Discrimination Methods for the Classification of Tumors Using Gene Expression DataJournal of the American Statistical Association, 2002
- Noninvasive Diagnosis of Renal-Allograft Rejection by Measurement of Messenger RNA for Perforin and Granzyme B in UrineNew England Journal of Medicine, 2001
- Improved Graft Survival after Renal Transplantation in the United States, 1988 to 1996New England Journal of Medicine, 2000
- Long-term survival in renal transplant recipients with graft functionKidney International, 2000
- Comparison of Mortality in All Patients on Dialysis, Patients on Dialysis Awaiting Transplantation, and Recipients of a First Cadaveric TransplantNew England Journal of Medicine, 1999
- The Banff 97 working classification of renal allograft pathologyKidney International, 1999
- Serum amyloid A protein is a clinically useful indicator of acute renal allograft rejectionNephrology Dialysis Transplantation, 1997
- THE CORRELATION OF BANFF SCORING WITH REVERSIBILITY OF FIRST AND RECURRENT REJECTION EPISODESTransplantation, 1996